WSES consensus conference: Guidelines for first-line management of intra-abdominal infections

1.

Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG: Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010, 15,50 (2): 133-6. 10.1086/649554.

2.

Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ, Schunemann H: Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians task force. Chest. 2006, 129: 174-181. 10.1378/chest.129.1.174.PubMed

3.

Brozek JL, Akl EA, Jaeschke R, Lang DM, Bossuyt P, Glasziou P, Helfand M, Ueffing E, Alonso-Coello P, Meerpohl J, Phillips B, Horvath AR, Bousquet J, Guyatt GH, Schunemann HJ: Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy. 2009, 64: 1109-1116. 10.1111/j.1398-9995.2009.02083.x.PubMed

4.

Moore LJ, Moore FA, Jones SL, Xu J, Bass BL: Sepsis in general surgery: a deadly complication. Am J Surg. 2009, 198 (6): 868-74. 10.1016/j.amjsurg.2009.05.025.PubMed

5.

Moore LJ, Moore FA, Todd SR, Jones SL, Turner KL, Bass BL: Sepsis in general surgery: the 2005-2007 national surgical quality improvement program perspective. Arch Surg. 2010, 145 (7): 695-700. 10.1001/archsurg.2010.107.PubMed

6.

Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008, 36 (1): 296-327. 10.1097/01.CCM.0000298158.12101.41.PubMed

7.

Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ, American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidlines for the use of innovative therapies in sepsis. Chest. 1992, 101: 1644-1655. 10.1378/chest.101.6.1644.PubMed

8.

Calandra T: Pathogenesis of septic shock: implications for prevention and treatment. J Chemother. 2001, 13 (Spec No 1(1)): 173-80. ReviewPubMed

9.

Bochud PY, Calandra T: Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ. 2003, 326: 262-6. 10.1136/bmj.326.7383.262.PubMedCentralPubMed

10.

Dinarello CA: Proinfiammatory and anti-infiammatory cytokines as mediators in the pathogenesis of septic shock. Chest. 1997, 112: 321S-329S. 10.1378/chest.112.6_Supplement.321S.PubMed

11.

Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Eng J Med. 2001, 345: 1368-1377. 10.1056/NEJMoa010307.

12.

Vincent JL, Biston P, Devriendt J, Brasseur A, De Backer D: Dopamine versus norepinephrine: is one better?. Minerva Anestesiol. 2009, 75 (5): 333-337.PubMed

13.

Hollenberg SM: Vasopressor support in septic shock. Chest. 2007, 132 (5): 1678-1687. 10.1378/chest.07-0291.PubMed

14.

Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J: Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000, 356: 2139-2143. 10.1016/S0140-6736(00)03495-4.PubMed

15.

Kellum J, Decker J: Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med. 2001, 29: 1526-1531. 10.1097/00003246-200108000-00005.PubMed

16.

Hesselvik JF, Brodin B: Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport. Crit Care Med. 1989, 17: 179-180. 10.1097/00003246-198902000-00016.PubMed

17.

Meadows D, Edwards JD, Wilkins RG, Nightingale P: Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med. 1988, 16: 663-667. 10.1097/00003246-198807000-00003.PubMed

18.

Martin C, Papazian L, Perrin G, Saux P, Gouin F: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest. 1993, 103: 1826-1831. 10.1378/chest.103.6.1826.PubMed

19.

Patel GP, Grahe JS, Sperry M, Singla S, Elpern E, Lateef O, Balk RA: Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock. 2010, 33 (4): 375-80. 10.1097/SHK.0b013e3181c6ba6f.PubMed

20.

Flancbaum L, Dick M, Dasta J, Sinha R, Choban P: A dose-response study of phenylephrine in critically ill, septic surgical patients. Eur J Clin Pharmacol. 1997, 51: 461-465. 10.1007/s002280050231.PubMed

21.

De Backer D, Creteur J, Silva E, Vincent JL: Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?. Crit Care Med. 2003, 31 (6): 1659-67. 10.1097/01.CCM.0000063045.77339.B6.PubMed

22.

Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, Totaro R, Vincent JL, Zanotti-Cavazzoni S: Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med. 2004, 32: 1928-1948. 10.1097/01.CCM.0000139761.05492.D6.PubMed

23.

Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C, Troché G, Ricard JD, Nitenberg G, Papazian L, Azoulay E, Bellissant E, CATS Study Group: Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet. 2007, 370 (9588): 676-84. 10.1016/S0140-6736(07)61344-0.PubMed

24.

Holmes CL, Patel BM, Russell JA, Walley KR: Physiology of vasopressin relevant to management of septic shock. Chest. 2001, 120 (3): 989-1002. 10.1378/chest.120.3.989.PubMed

25.

Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008, 358 (9): 877-87. 10.1056/NEJMoa067373.PubMed

26.

Azzarello G, Lanteri R, Rapisarda C, Santangelo M, Racalbuto A, Minutolo V, Di Cataldo A, Licata A: Ultrasound-guided percutaneous treatment of abdominal collections. Chir Ital. 2009, 61 (3): 337-340.PubMed

27.

Gazelle GS, Mueller PR: Abdominal abscess: Imaging and intervention. Radiol Clin North Am. 1994, 32: 913-932.PubMed

28.

VanSonnenberg E, Ferrucci JT, Mueller PR, Wittenberg J, Simeone JF: Percutaneous drainage of abscesses and fluid collections: Technique, results, and applications. Radiology. 1982, 142: 1-10.PubMed

29.

Bouali K, Magotteaux P, Jadot A, Saive C, Lombard R, Weerts J, Dallemagne B, Jehaes C, Delforge M, Fontaine F: Percutaneous catheter drainage of abdominal abscess after abdominal surgery: Results in 121 cases. J Belg Radiol. 1993, 76: 11-14.PubMed

30.

VanSonnenberg E, Wing VW, Casola G, Coons HG, Nakamoto SK, Mueller PR, Ferrucci JT, Halasz NA, Simeone JF: Temporizing effect of percutaneous drainage of complicated abscesses in critically ill patients. Am J Roentgenol. 1984, 142: 821-826.

31.

Bufalari A, Giustozzi G, Moggi L: Postoperative intra-abdominal abscesses: Percutaneous versus surgical treatment. Acta Chir Belg. 1996, 96 (5): 197-200.PubMed

32.

VanSonnenberg E, Mueller PR, Ferrucci JT: Percutaneous drainage of 250 abdominal abscesses and fluid collections. I. Results, failures, and complications. Radiology. 1984, 151: 337-341.PubMed

33.

Jaffe TA, Nelson RC, DeLong D, Paulson EK: Practice Patterns in Percutaneous Image-guided Intra-abdominal Abscess Drainage: Survey of Academic and Private Practice Centres. Radiology. 2004, 233 (3): 750-6. 10.1148/radiol.2333032063.PubMed

34.

Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L: Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010, 54 (11): 4851-63. 10.1128/AAC.00627-10.PubMedCentralPubMed

35.

Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, Dupont H: Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother. 2009, 63 (4): 785-94. 10.1093/jac/dkp005.PubMed

36.

Swenson BR, Metzger R, Hedrick TL, McElearney ST, Evans HL, Smith RL, Chong TW, Popovsky KA, Pruett TL, Sawyer RG: Choosing antibiotics for intra-abdominal infections: what do we mean by "high risk"?. Surg Infect (Larchmt). 2009, 10 (1): 29-39. 10.1089/sur.2007.041.

37.

Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, Hennequin C, Martin C: Candida as a risk factor for mortality in peritonitis. Crit Care Med. 2006, 34 (3): 646-52. 10.1097/01.CCM.0000201889.39443.D2.PubMed

38.

Montravers P, Mira JP, Gangneux JP, Leroy O, Lortholary O, the AmarCand study group: A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect. 2010

39.

Lumb J: Carbapenems in the treatment of intra-abdominal infection. Report from the 20th European Congress of Clinical Microbiology and Infectious Diseases. Vienna, Austria, 10-13 April 2010. Future Microbiol. 2010, 5 (8): 1165-6. 10.2217/fmb.10.87.PubMed

40.

Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Cantón R, Baquero F: Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother. 2010, 54 (7): 3043-6. 10.1128/AAC.00265-10.PubMedCentralPubMed

41.

Coque TM, Baquero F, Canton R: Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 2008, 13 (47): [http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19044]

42.

Vatopoulos A: High rates of metallo-beta-lactamase-producing Klebsiella neumoniae in Greece - a review of the current evidence. Euro Surveill. 2008, 13 (4):

43.

Ho J, Tambyah PA, Paterson DL: Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis. 2010, 23 (6): 546-53. 10.1097/QCO.0b013e32833f0d3e.PubMed

44.

Ho J, Tambyah PA, Paterson DL: Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis. 2010, 23 (6): 546-53. 10.1097/QCO.0b013e32833f0d3e.PubMed

45.

Riché FC, Dray X, Laisné MJ, Matéo J, Raskine L, Sanson-Le Pors MJ, Payen D, Valleur P, Cholley BP: Factors associated with septic shock and mortality in generalized peritonitis: Comparison between community-acquired and postoperative peritonitis. Crit Care. 2009, 13 (3): R99.PubMedCentralPubMed

46.

Pea F, Viale P, Furlanut M: Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Clin Pharmacokinet. 2005, 44: 1009-1034. 10.2165/00003088-200544100-00002.PubMed

47.

Pea F, Viale P: Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?. Crit Care. 2009, 13 (3): 214-10.1186/cc7774.PubMedCentralPubMed

48.

Ho J, Tambyah PA, Paterson DL: Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis. 2010, 23 (6): 546-53. 10.1097/QCO.0b013e32833f0d3e.PubMed

49.

Pea F, Brollo L, Viale P, Pavan F, Furlanut M: Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose. J Antimicrob Chemother. 2003, 51 (4): 971-5. 10.1093/jac/dkg147.PubMed

50.

Pea F, Viale P: The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?. Clin Infect Dis. 2006, 42 (12): 1764-71. 10.1086/504383.PubMed

51.

Craig WA: Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am. 2003, 17 (3): 479-501. 10.1016/S0891-5520(03)00065-5.PubMed

52.

Lorente L, Jiménez A, Martín MM: Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion. Int J Antimicrob Agents. 2009, 33 (5): 464-8. 10.1016/j.ijantimicag.2008.10.025.PubMed

53.

Lorente L, Lorenzo L, Martín MM, Jiménez A, Mora ML: Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli. Ann Pharmacother. 2006, 40 (2): 219-23. 10.1345/aph.1G467.PubMed

54.

Roberts JA, Lipman J, Blot S, Rello J: Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?. Curr Opin Crit Care. 2008, 14 (4): 390-6. 10.1097/MCC.0b013e3283021b3a.PubMed

55.

Mueller EW, Boucher BA: The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients. Surg Infect (Larchmt). 2009, 10 (6): 563-70. 10.1089/sur.2007.080.

56.

Chakraborty A, Roy S, Loeffler J, Chaves RL: Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injection. J Antimicrob Chemother. 2009, 64 (1): 151-8. 10.1093/jac/dkp155.PubMedCentralPubMed

57.

Menichetti F, Sganga G: Definition and classification of intra-abdominal infections. J Chemother. 2009, Suppl 1: 3-4.

58.

Malangoni MA, Inui T: Peritonitis - the Western experience. World J Emerg Surg. 2006, 1: 25-10.1186/1749-7922-1-25.PubMedCentralPubMed

59.

Pieracci FM, Barie PS: Management of severe sepsis of abdominal origin. Scand J Surg. 2007, 96 (3): 184-96.PubMed

60.

Osborn TM, Nguyen HB, Rivers EP: Emergency medicine and the surviving sepsis campaign: an international approach to managing severe sepsis and septic shock. Ann Emerg Med. 2005, 46 (3): 228-31. 10.1016/j.annemergmed.2005.04.007.PubMed

61.

Esteban A, Frutos-Vivar F, Ferguson ND, Peñuelas O, Lorente JA, Gordo F, Honrubia T, Algora A, Bustos A, García G, Diaz-Regañón IR, de Luna RR: Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med. 2007, 35 (5): 1284-9. 10.1097/01.CCM.0000260960.94300.DE.PubMed

62.

Emmi V, Sganga G: Diagnosis of intra-abdominal infections: clinical findings and imaging. Infez Med. 2008, Suppl 1: 19-30.

63.

Bartolozzi C: Imaging and invasive techniques for diagnosis and treatment of surgical infections. Surg Infect (Larchmt). 2006, 7 (Suppl 2): S97-9.

64.

Foinant M, Lipiecka E, Buc E, Boire JY, Schmidt J, Garcier JM, Pezet D, Boyer L: Impact of computed tomography on patient's care in non-traumatic acute abdomen: 90 patients. J Radiol. 2007, 88 (4): 559-566. 10.1016/S0221-0363(07)89855-6.PubMed

65.

Emmi V, Sganga G: Clinical diagnosis of intra-abdominal infections. J Chemother. 2009, 21 (Suppl 1): 12-8.PubMed

66.

Puylaert JB, van der Zant FM, Rijke AM: Sonography and the acute abdomen: practical considerations. Am J Roentgenol. 1997, 168 (1): 179-86.

67.

Doria AS, Moineddin R, Kellenberger CJ, Epelman M, Beyene J, Schuh S, Babyn PS, Dick PT: US or CT for diagnosis of appendicitis in children and adults? A meta-analysis. Radiology. 2006, 241: 83-94. 10.1148/radiol.2411050913.PubMed

68.

TJ, Park KG, Steele RJ, Chung SS, Li AK: A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med. 1989, 320: 970-973. 10.1056/NEJM198904133201504.PubMed

69.

Boey J, Lee NW, Koo J, Lam PH, Wong J, Ong GB: Immediate definitive surgery for perforated duodenal ulcers: a prospective controlled trial. Ann Surg. 1982, 196: 338-344. 10.1097/00000658-198209000-00013.PubMedCentralPubMed

70.

Millat B, Fingerhut A, Borie F: Surgical treatment of complicated duodenal ulcers: controlled trials. World J Surg. 2000, 24: 299-306. 10.1007/s002689910048.PubMed

71.

Crisp E: Cases of perforation of the stomach with deductions therefrom relative to the character and treatment of that lesion. Lancet. 1843 (2): 639.

72.

Wangensteen OH: Nonoperative treatment of localized perforations of the duodenum. Minn Med. 1935, 18: 477-480.

73.

Taylor H: Peptic ulcer perforation treated without operation. Lancet. 1946, 2: 441-444. 10.1016/S0140-6736(46)90971-3.PubMed

74.

Crofts TJ, Park KG, Steele RJ, Chung SS, Li AK: A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med. 1989, 320: 970-973. 10.1056/NEJM198904133201504.PubMed

75.

Bucher P, Oulhaci W, Morel P, Ris F, Huber O: Results of conservative treatment for perforated gastroduodenal ulcers in patients not eligible for surgical repair. Swiss Med Wkly. 2007, 137: 337-340.PubMed

76.

Sogne B, Jean F, Foulatier O, Khalil H, Scotté M: Non operative treatment for perforated peptic ulcer: results of a prospective study. Ann Chir. 2004, 129: 578-582. 10.1016/j.anchir.2004.06.012.

77.

Crofts TJ, Park KG, Steele RJ, Chung SS, Li AK: A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med. 1989, 320: 970-973. 10.1056/NEJM198904133201504.PubMed

78.

Bucher P, Oulhaci W, Morel P, Ris F, Huber O: Results of conservative treatment for perforated gastroduodenal ulcers in patients not eligible for surgical repair. Swiss Med Wkly. 2007, 137: 337-340.PubMed

79.

Sogne B, Jean F, Foulatier O, Khalil H, Scotté M: Non operative treatment for perforated peptic ulcer: results of a prospective study. Ann Chir. 2004, 129: 578-582. 10.1016/j.anchir.2004.06.012.

80.

Boey J, Choi SKI, Poon A: Risk stratification in perforated duodenal ulcers. Ann Surg. 1987, 205: 22-26. 10.1097/00000658-198701000-00005.PubMedCentralPubMed

81.

Crofts TJ, Park KG, Steele RJ, Chung SS, Li AK: A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med. 1989, 320: 970-973. 10.1056/NEJM198904133201504.PubMed

82.

Sogne B, Jean F, Foulatier O, Khalil H, Scotté M: Non operative treatment for perforated peptic ulcer: results of a prospective study. Ann Chir. 2004, 129: 578-5827. 10.1016/j.anchir.2004.06.012.

83.

Svanes C, Lie RT, Svanes K, Lie SA, Soreide O: Adverse effects of delayed treatment for perforated peptic ulcer. Ann Surg. 1994, 220 (2): 168-75. 10.1097/00000658-199408000-00008.PubMedCentralPubMed

84.

Boey J, Lee NW, Koo J, Lam PH, Wong J, Ong GB: Immediate definitive surgery for perforated duodenal ulcers: a prospective controlled trial. Ann Surg. 1982, 196: 338-344. 10.1097/00000658-198209000-00013.PubMedCentralPubMed

85.

Tanphiphat C, Tanprayoon T, Nathalong A: Surgical treatment of perforated duodenal ulcer: A prospective trial between simple closure and definitive surgery. Br J Surg. 1985, 72: 370-10.1002/bjs.1800720513.PubMed

86.

Christiansen J, Andersen OB, Bonnesen T, Baekgaard N: Perforated duodenal ulcer managed by simple closure versus closure and proximal gastric vagotomy. Br J Surg. 1987, 74 (4): 286-7. 10.1002/bjs.1800740420.PubMed

87.

Hay JM, Lacaine F, Kohlmann G, Fingerhut A: Immediate definitive surgery for perforated duodenal ulcer does not increase operative mortality: a prospective controlled trial. World J Surg. 1988, 12 (5): 705-9. 10.1007/BF01655894.PubMed

88.

Mikulicz J: Ueber Laparotomie bei Magen und Darmperforation. Samml Klin Vort Leipzig. 1885, 262: 2307.

89.

Cellan-Jones CJ: A rapid method of treatment in perforated duodenal ulcer. BMJ. 1929, 1076-1077. 10.1136/bmj.1.3571.1076.

90.

Graham RR: The treatment of perforated duodenal ulcers. Surg Gynecol Obstet. 1937, 235-238.

91.

Lau WY, Leung KL, Kwong KH, Davey IC, Robertson C, Dawson JJ, Chung SC, Li AK: A randomized study comparing laparoscopic versus open repair of perforated peptic ulcer using suture or sutureless technique. Ann Surg. 1996, 224: 131-138. 10.1097/00000658-199608000-00004.PubMedCentralPubMed

92.

Boey J, Lee NW, Koo J, Lam PH, Wong J, Ong GB: Immediate definitive surgery for perforated duodenal ulcers: a prospective controlled trial. Ann Surg. 1982, 196: 338-344. 10.1097/00000658-198209000-00013.PubMedCentralPubMed

93.

Tanphiphat C, Tanprayoon T, Nathalong A: Surgical treatment of perforated duodenal ulcer: A prospective trial between simple closure and definitive surgery. Br J Surg. 1985, 72: 370-10.1002/bjs.1800720513.PubMed

94.

Christiansen J, Andersen OB, Bonnesen T, Baekgaard N: Perforated duodenal ulcer managed by simple closure versus closure and proximal gastric vagotomy. Br J Surg. 1987, 74 (4): 286-7. 10.1002/bjs.1800740420.PubMed

95.

Hay JM, Lacaine F, Kohlmann G, Fingerhut A: Immediate definitive surgery for perforated duodenal ulcer does not increase operative mortality: a prospective controlled trial. World J Surg. 1988, 12 (5): 705-9. 10.1007/BF01655894.PubMed

96.

Ng EK, Lam YH, Sung JJ, Yung MY, To KF, Chan AC, Lee DW, Law BK, Lau JY, Ling TK, Lau WY, Chung SC: Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg. 2000, 231 (2): 153-8. 10.1097/00000658-200002000-00001.PubMedCentralPubMed

97.

Haberer Von, Zur H: Therapie akuter Geschwursperforationen des Magens und Duodenums in die freie Bauchhohle. Wien Klin Wochnschr. 1919, 32: 413.

98.

Sarath Chandra SS, Kumar SS: Definitive or conservative surgery for perforated gastric ulcer? An unresolved problem. Int J Surg. 2009, 7: 136-139. 10.1016/j.ijsu.2008.12.037.PubMed

99.

Turner WW, Thompson WM, Thal ER: Perforated gastric ulcers. A plea for management by simple closures. Arch Surg. 1988, 123 (8): 960-4.PubMed

100.

Wysocki A, Biesiada Z, Beben P, Budzynski A: Perforated gastric ulcer. Dig Surg. 2000, 17: 132-7. 10.1159/000018815.PubMed

101.

Tsugawa K, Koyanagi N, Hashizume M, Tomikawa M, Akahoshi K, Ayukawa K: The therapeutic strategies in performing emergency surgery for gastroduodenal ulcer perforation in 130 patients over 70 years of age. Hepatogastroenterology. 2001, 48 (37): 156-62.PubMed

102.

Sanabria A, Villegas MI, Morales Uribe CH: Laparoscopic repair for perforated peptic ulcer disease. Cochrane Database of Systematic Reviews. 2010, Issue 4.

103.

Lau H: Laparoscopic repair of perforated peptic ulcer: a meta-analysis. Surg Endosc. 2004, 18 (7): 1013-21. 10.1007/s00464-003-8266-y.PubMed

104.

Lau WY, Leung KL, Kwong KH, Davey IC, Robertson C, Dawson JJ, Chung SC, Li AK: A randomized study comparing laparoscopic versus open repair of perforated peptic ulcer using suture or sutureless technique. Annals of Surgery. 1996, 224: 131-8. 10.1097/00000658-199608000-00004.PubMedCentralPubMed

105.

Siu WT, Leong HT, Law BK, Chau CH, Li AC, Fung KH, Tai YP, Li MK: Laparoscopic repair for perforated peptic ulcer: a randomized controlled trial. Annals of Surgery. 2002, 235: 313-9. 10.1097/00000658-200203000-00001.PubMedCentralPubMed

106.

Bertleff MJ, Halm JA, Bemelman WA, van der Ham AC, van der Harst E, Oei HI, Smulders JF, Steyerberg EW, Lange JF: Randomized clinical trial of laparoscopic versus open repair of the perforated peptic ulcer: the LAMA Trial. World Journal of Surgery. 2009, 33: 1368-73. 10.1007/s00268-009-0054-y.PubMedCentralPubMed

107.

Gertsch P, Choe LWC, Yuen ST, Chau KY, Lauder IJ: Long term survival after gastrectomy for advanced bleeding or perforated gastric carcinoma. Eur J Surg. 1996, 162: 723-727.PubMed

108.

Lehnert T, Buhl K, Dueck M, Hinz U, Herfarth C: Two-stage radical gastrectomy for perforated gastric cancer. Eur J Surg Oncol. 2000, 26: 780-784. 10.1053/ejso.2000.1003.PubMed

109.

Ozmen MM, Zulfikaroglu B, Kece C, Aslar AK, Ozalp N, Koc M: Factors influencing mortality in spontaneous gastric tumour perforations. J Int Med Res. 2002, 30: 180-184.PubMed

110.

So JBY, Yam A, Cheah WK, Kum CK, Goh PM: Risk factors related to operative mortality and morbidity in patients undergoing emergency gastrectomy. Br J Surg. 2000, 87: 1702-1707. 10.1046/j.1365-2168.2000.01572.x.PubMed

111.

Roviello F, Simone R, Marrelli D: Perforated gastric carcinoma: a report of 10 cases and review of the literature. World J Surg Oncol. 2006, 4: 19-24. 10.1186/1477-7819-4-19.PubMedCentralPubMed

112.

Jwo S, Chien R, Chao T: Clinicopathalogical features, surgical management, and disease outcome of perforated gastric cancer. J Surg Oncol. 2005, 91: 219-25. 10.1002/jso.20307.PubMed

113.

Adachi Y, Mori M, Maehara Y: Surgical results of perforated gastric carcinoma: an analysis of 155 Japanese patients. Am J Gastroenterol. 1997, 92: 516-8.PubMed

114.

Lehnert T, Buhl K, Dueck M: Two-stage radical gastrectomy for perforated gastric cancer. Eur J Surg Oncol. 2000, 26: 780-4. 10.1053/ejso.2000.1003.PubMed

115.

Ayite A, Dosseh DE, Tekou HA, James K: Surgical treatment of singl non traumatic perforation of small bowel: excision-suture or resection-anastomosis. Ann Chir. 2005, 131 (2): 91-5. 10.1016/j.anchir.2005.11.008. (EL 3b)PubMed

116.

Kirkpatrick AW, Baxter KA, Simons RK, Germann E, Lucas CE, Ledgerwood AM: Intra-abdominal complications after surgical repair of small bowel injuries: an international reiew. J Trauma. 2003, 55 (3): 399-406. 10.1097/01.TA.0000060248.87046.EE.PubMed

117.

Kirkpatrick AW, Baxter KA, Simons RK, Germann E, Lucas CE, Ledgerwood AM: Intra-abdominal complications after surgical repair of small bowel injuries: an international reiew. J Trauma. 2003, 55 (3): 399-406. 10.1097/01.TA.0000060248.87046.EE.PubMed

118.

Ayite A, Dosseh DE, Tekou HA, James K: Surgical treatment of single non traumatic perforation of small bowel: excision-suture or resection-anastomosis. Ann Chir. 2005, 131 (2): 91-5. 10.1016/j.anchir.2005.11.008. (EL 3b)PubMed

119.

Kirkpatrick AW, Baxter KA, Simons RK, Germann E, Lucas CE, Ledgerwood AM: Intra-abdominal complications after surgical repair of small bowel injuries: an international reiew. J Trauma. 2003, 55 (3): 399-406. 10.1097/01.TA.0000060248.87046.EE.PubMed

120.

Kirkpatrick AW, Baxter KA, Simons RK, Germann E, Lucas CE, Ledgerwood AM: Intra-abdominal complications after surgical repair of small bowel injuries: an international reiew. J Trauma. 2003, 55 (3): 399-406. 10.1097/01.TA.0000060248.87046.EE.PubMed

121.

De Graaf JS, van Goor H, Blechrodt RP: Primary small bowel anastomosis in generalized peritonitis. Eur j Surg. 1996, 162 (1): 55-8.PubMed

122.

Sinha R, Sharma N, Joshi M: Laparoscopic repair of small bowel perforation. JSLS. 2005, 9: 399-402.PubMedCentralPubMed

123.

Hansson J, Körner U, Khorram-Manesh A, Solberg A, Lundholm K: Randomized clinical trial of antibiotic therapy versus appendicectomy as primary treatment of acute appendicitis in unselected patients. Br J Surg. 2009, 96: 473-481. 10.1002/bjs.6482.PubMed

124.

Styrud J, Eriksson S, Nilsson I, Ahlberg G, Haapaniemi S, Neovius G, Rex L, Badume I, Granström L: Appendectomy versus antibiotic treatment in acute appendicitis. A prospective multicenter randomized controlled trial. World J Surg. 2006, 30: 1033-1037. 10.1007/s00268-005-0304-6.PubMed

125.

Eriksson S, Granström L: Randomized controlled trial of appendicectomy versus antibiotic therapy for acute appendicitis. Br J Surg. 1995, 82: 166-169. 10.1002/bjs.1800820207.PubMed

126.

Varadhan KK, Humes DJ, Neal KR, Lobo DN: Antibiotic therapy versus appendectomy for acute appendicitis: a meta-analysis. World J Surg. 2010, 34: 199-209. 10.1007/s00268-009-0343-5.PubMed

127.

Taylor M, Emil S, Nguyen N, Ndiforchu F: Emergent vs urgent appendectomy in children: a study of outcomes. J Pediatr Surg. 2005, 40: 1912-1915. 10.1016/j.jpedsurg.2005.08.005.PubMed

128.

Ditillo MF, Dziura JD, Rabinovici R: Is it safe to delay appendectomy in adults with acute appendicitis?. Ann Surg. 2006, 244: 656-660. 10.1097/01.sla.0000231726.53487.dd.PubMedCentralPubMed

129.

Sauerland S, Lefering R, Neugebauer EA: Laparoscopic versus open surgery for suspected appendicitis. Cochrane Database Syst Rev. 2002, CD001546.

130.

Faiz O, Clark J, Brown T, Bottle A, Antoniou A, Farrands P, Darzi A, Aylin P: Traditional and laparoscopic appendectomy in adults: outcomes in English NHS hospitals between 1996 and 2006. Ann Surg. 2008, 248: 800-806. 10.1097/SLA.0b013e31818b770c.PubMed

131.

Sporn E, Petroski GF, Mancini GJ, Astudillo JA, Miedema BW, Thaler K: Laparoscopic appendectomy--is it worth the cost? Trend analysis in the US from 2000 to 2005. J Am Coll Surg. 2009, 208: 179-185. 10.1016/j.jamcollsurg.2008.10.026.PubMed

132.

Oliak D, Yamini D, Udani VM, Lewis RJ, Arnell T, Vargas H, Stamos MJ: Initial nonoperative management for periappendiceal abscess. Dis Colon Rectum. 2001, 44: 936-941. 10.1007/BF02235479.PubMed

133.

Brown CV, Abrishami M, Muller M, Velmahos GC: Appendiceal abscess: immediate operation or percutaneous drainage?. Am Surg. 2003, 69: 829-832.PubMed

134.

Andersson RE, Petzold MG: Nonsurgical treatment of appendiceal abscess or phlegmon: a systematic review and meta-analysis. Ann Surg. 2007, 246: 741-748. 10.1097/SLA.0b013e31811f3f9f.PubMed

135.

Corfield L: Interval appendicectomy after appendiceal mass or abscess in adults: what is "best practice"?. Surg Today. 2007, 37: 1-4. 10.1007/s00595-006-3334-2.PubMed

136.

Kaminski A, Liu IL, Applebaum H, Lee SL, Haigh PI: Routine interval appendectomy is not justified after initial nonoperative treatment of acute appendicitis. Arch Surg. 2005, 140: 897-901. 10.1001/archsurg.140.9.897.PubMed

137.

Rafferty J, Shellito P, Hyman NH, Buie WD: Standards Committee of American Society of Colon and Rectal Surgeons: Practice parameters for sigmoid diverticulitis. Dis Colon Rectum. 2006, 49: 939-944. 10.1007/s10350-006-0578-2.PubMed

138.

Wong WD, Wexner SD, Lowry A, Vernava A, Burnstein M, Denstman F, Fazio V, Kerner B, Moore R, Oliver G, Peters W, Ross T, Senatore P, Simmang C: Practice parameters for the treatment of sigmoid diverticulitis--supporting documentation. The Standards Task Force. The American Society of Colon and Rectal Surgeons. Dis Colon Rectum. 2000, 43: 290-297. 10.1007/BF02258291.PubMed

139.

Patient Care Committee of the Society for Surgery of the Alimentary Tract (SSAT): Surgical treatment of diverticulitis. J Gastrointest Surg. 1999, 3: 212-213. 10.1016/S1091-255X(99)80037-7.

140.

Stollman NH, Raskin JB: Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1999, 94: 3110-3121. 10.1111/j.1572-0241.1999.01501.x.PubMed

141.

Köhler L, Sauerland S, Neugebauer E: Diagnosis and treatment of diverticular disease: results of a consensus development conference. The Scientific Committee of the European Association for Endoscopic Surgery. Surg Endosc. 1999, 13: 430-436.PubMed

142.

Hinchey EJ, Schaal PG, Richards GK: Treatment of perforated diverticular disease of the colon. Adv Surg. 1978, 12: 85-109.PubMed

143.

Ambrosetti P, Jenny A, Becker C, Terrier TF, Morel P: Acute left colonic diverticulitis--compared performance of computed tomography and water-soluble contrast enema: prospective evaluation of 420 patients. Dis Colon Rectum. 2000, 43: 1363-1367. 10.1007/BF02236631.PubMed

144.

Stollman N, Raskin JB: Diverticular disease of the colon. Lancet. 2004, 363: 631-639. 10.1016/S0140-6736(04)15597-9.PubMed

145.

Jacobs DO: Clinical practice. Diverticulitis. N Engl J Med. 2007, 357: 2057-2066. 10.1056/NEJMcp073228.PubMed

146.

Broderick-Villa G, Burchette RJ, Collins JC, Abbas MA, Haigh PI: Hospitalization for acute diverticulitis does not mandate routine elective colectomy. Arch Surg. 2005, 140: 576-581. 10.1001/archsurg.140.6.576.PubMed

147.

Mueller MH, Glatzle J, Kasparek MS, Becker HD, Jehle EC, Zittel TT, Kreis ME: Long-term outcome of conservative treatment in patients with diverticulitis of the sigmoid colon. Eur J Gastroenterol Hepatol. 2005, 17: 649-654. 10.1097/00042737-200506000-00009.PubMed

148.

Ambrosetti P, Robert J, Witzig JA, Mirescu D, de Gautard R, Borst F, Rohner A: Incidence, outcome, and proposed management of isolated abscesses complicating acute left-sided colonic diverticulitis: a prospective study of 140 patients. Dis Colon Rectum. 1992, 35: 1072-1076. 10.1007/BF02252998.PubMed

149.

Siewert B, Tye G, Kruskal J, Sosna J, Opelka F, Raptopoulos V, Goldberg SN: Impact of CT-guided drainage in the treatment of diverticular abscesses: size matters. AJR Am J Roentgenol. 2006, 186: 680-686. 10.2214/AJR.04.1708. [Erratum, AJR Am J Roentgenol 2007; 189:512.]PubMed

150.

Kumar RR, Kim JT, Haukoos JS, Macias LH, Dixon MR, Stamos MJ, Konyalian VR: Factors affecting the successful management of intra-abdominal abscesses with antibiotics and the need for percutaneous drainage. Dis Colon Rectum. 2006, 49: 183-189. 10.1007/s10350-005-0274-7.PubMed

151.

McKee RF, Deignan RW, Krukowski ZH: Radiological investigation in acute diverticulitis. Br J Surg. 1993, 80: 560-565. 10.1002/bjs.1800800506.PubMed

152.

Padidar AM, Jeffrey RB, Mindelzun RE, Dolph JF: Differentiating sigmoid diverticulitis from carcinoma on CT scans: mesenteric inflammation suggests diverticulitis. AJR Am J Roentgenol. 1994, 163: 81-83.PubMed

153.

Stabile BE, Puccio E, vanSonnenberg E, Neff CC: Preoperative percutaneous drainage of diverticular abscesses. Am J Surg. 1990, 159: 99-104. 10.1016/S0002-9610(05)80613-0.PubMed

154.

Kaiser AM, Jiang JK, Lake JP, Ault G, Artinyan A, Gonzalez-Ruiz C, Essani R, Beart RW: The management of complicated diverticulitis and the role of computed tomography. Am J Gastroenterol. 2005, 100: 910-917. 10.1111/j.1572-0241.2005.41154.x.PubMed

155.

Biondo S, Parés D, Martí-Ragué J, Kreisler E, Fraccalvieri D, Jaurrieta E: Acute colonic diverticulitis in patients under 50 years of age. Br J Surg. 2002, 89: 1137-1141. 10.1046/j.1365-2168.2002.02195.x.PubMed

156.

Schoetz DJ: Diverticular disease of the colon: a century-old problem. Dis Colon Rectum. 1999, 42: 703-709. 10.1007/BF02236921.PubMed

157.

Thaler K, Baig MK, Berho M, Weiss EG, Nogueras JJ, Arnaud JP, Wexner SD, Bergamaschi R: Determinants of recurrence after sigmoid resection for uncomplicated diverticulitis. Dis Colon Rectum. 2003, 46: 385-388. 10.1007/s10350-004-6560-y.PubMed

158.

Schwandner O, Farke S, Fischer F, Eckmann C, Schiedeck TH, Bruch HP: Laparoscopic colectomy for recurrent and complicated diverticulitis: a prospective study of 396 patients. Langenbecks Arch Surg. 2004, 389: 97-103. 10.1007/s00423-003-0454-7.PubMed

159.

Guller U, Jain N, Hervey S, Purves H, Pictoobon R: Laparoscopic vs. open colectomy: outcomes comparison based on large nationwide databases. Arch Surg. 2003, 138: 1179-1186. 10.1001/archsurg.138.11.1179.PubMed

160.

Dwivedi A, Chahin F, Agrawal S, Chau WY, Tootla A, Tootla F, Silva YJ: Laparoscopic colectomy vs. open colectomy for sigmoid diverticular disease. Dis Colon Rectum. 2002, 45: 1309-1314. 10.1007/s10350-004-6415-6.PubMed

161.

Tuech JJ, Pessaux P, Rouge C, Regenet N, Bergamaschi R, Arnaud JP: Laparoscopic vs. open colectomy for sigmoid diverticulitis: a prospective comparative study in the elderly. Surg Endosc. 2000, 14: 1031-1033. 10.1007/s004640000267.PubMed

162.

Bartus CM, Lipof T, Sarwar CM, Vignati PV, Johnson KH, Sardella WV, Cohen JL: Colovesicle fistula: not a contraindication to elective laparoscopic colectomy. Dis Colon Rectum. 2005, 48: 233-236. 10.1007/s10350-004-0849-8.PubMed

163.

Chapman J, Davies M, Wolff B, Dozois E, Tessier D, Harrington J, Larson D: Complicated diverticulitis: is it time to rethink the rules?. Ann Surg. 2005, 242: 576-581.PubMedCentralPubMed

164.

Ordoñez CA, Puyana JC: Management of peritonitis in the critically ill patient. Surg Clin North Am. 2006, 86: 1323-1349.PubMedCentralPubMed

165.

Blot S, De Waele JJ: Critical issues in the clinical management of complicated intra-abdominal infections. Drugs. 2005, 65: 1611-1620. 10.2165/00003495-200565120-00002.PubMed

166.

Belmonte C, Klas JV, Perez JJ: The Hartmann procedure. First choice or last resort in diverticular disease?. Arch Surg. 1996, 131: 612-615.PubMed

167.

Rothenberger DA, Wiltz O: Surgery for complicated diverticulitis. Surg Clin North Am. 1993, 73: 975-992.PubMed

168.

Constantinides VA, Tekkis PP, Athanasiou T, Aziz O, Purkayastha S, Remzi FH, Fazio VW, Aydin N, Darzi A, Senapati A: Primary resection with anastomosis vs. Hartmann's procedure in nonelective surgery for acute colonic diverticulitis: a systematic review. Dis Colon Rectum. 2006, 49: 966-981. 10.1007/s10350-006-0547-9.PubMed

169.

Vermeulen J, Coene PPLO, van Hout NM, van der Harst E, Mannaerts GHH, Weidema WF, Lange JF: Restoration of bowel continuity after surgery for acute perforated diverticulitis: should Hartmann's procedure be considered a one-stage procedure?. Colorectal Dis. 2009, 11: 619-624. 10.1111/j.1463-1318.2008.01667.x.PubMed

170.

Nugent KP, Daniels P, Stewart B, Patankar R, Johnson CD: Quality of life in stoma patients. Dis Colon Rectum. 1999, 42: 1569-1574. 10.1007/BF02236209.PubMed

171.

Vermeulen J, Gosselink MP, Busschbach JJ, Lange JF: Avoiding or reversing Hartmann's procedure provides improved quality of life after perforated diverticulitis. J Gastrointest Surg. 2010, 14: 651-657. 10.1007/s11605-010-1155-5.PubMedCentralPubMed

172.

Salem L, Flum DR: Primary anastomosis or Hartmann's procedure for patients with diverticular peritonitis? A systematic review. Dis Colon Rectum. 2004, 47: 1953-1964. 10.1007/s10350-004-0701-1.PubMed

173.

Blair NP, Germann E: Surgical management of acute sigmoid diverticulitis. Am J Surg. 2002, 183: 525-528. 10.1016/S0002-9610(02)00830-9.PubMed

174.

Lee EC, Murray JJ, Coller JA, Roberts PL, Schoetz DJ: Intraoperative colonic lavage in nonelective surgery for diverticular disease. Dis Colon Rectum. 1997, 40: 669-674. 10.1007/BF02140895.PubMed

175.

Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, Buchman T, Dellinger EP, Jernigan J, Gorbach S, Chow AW, Bartlett J, Infectious Diseases Society of America: Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003, 15,37 (8): 997-1005. 10.1086/378702.

176.

Weigelt JA: Empiric treatment options in the management of complicated intra-abdominal infections. Cleve Clin J Med. 2007, 74 (Suppl 4): S29-37. 10.3949/ccjm.74.Suppl_4.S29.PubMed

177.

Oteo J, Pérez-Vázquez M, Campos J: Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis. 2010, 23 (4): 320-6. 10.1097/QCO.0b013e3283398dc1. ReviewPubMed

178.

Solomkin JS, Yellin AE, Rotstein OD, Christou NV, Dellinger EP, Tellado JM, Malafaia O, Fernandez A, Choe KA, Carides A, Satishchandran V, Teppler H, Protocol 017 Study Group: Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind,randomized comparative phase III trial. Ann Surg. 2003, 237 (2): 235-45. 10.1097/00000658-200302000-00013.PubMedCentralPubMed

179.

Malangoni MA, Song J, Herrington J, Choudhri S, Pertel P: Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections. Ann Surg. 2006, 244 (2): 204-11. 10.1097/01.sla.0000230024.84190.a8.PubMedCentralPubMed

180.

Mazuski JE: Antimicrobial treatment for intra-abdominal infections. Expert Opin Pharmacother. 2007, 8 (17): 2933-45. 10.1517/14656566.8.17.2933.PubMed

181.

Powell LL, Wilson SE: The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection. Surg Infect (Larchmt). 2000, 1 (1): 57-63. 10.1089/109629600321308.

182.

Lode HM: Rational antibiotic therapy and the position of ampicillin/sulbactam. Int J Antimicrob Agents. 2008, 32 (1): 10-28. 10.1016/j.ijantimicag.2008.02.004.PubMed

183.

Gin A, Dilay L, Karlowsky JA, Walkty A, Rubinstein E, Zhanel GG: Piperacillin-tazobactam: A beta-lactam/beta-lactamase inhibitor combination. Expert Rev Anti Infect Ther. 2007, 5 (3): 365-383. 10.1586/14787210.5.3.365.PubMed

184.

Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM: Antimicrobial resistance trends of Escherichia coli bloodstream isolates: A population-based study, 1998-2007. J Antimicrob Chemother. 2009, 64 (1): 169-174. 10.1093/jac/dkp162.PubMedCentralPubMed

185.

Paterson DL, Bonomo RA: Extended-Spectrum ß-Lactamases: A Clinical Update. Clin Microbiol Rev. 2005, 18 (4): 657-686. 10.1128/CMR.18.4.657-686.2005.PubMedCentralPubMed

186.

Paterson DL: Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control. 2006, 34 (5 Suppl 1): S20-8. 10.1016/j.ajic.2006.05.238.PubMed

187.

Murray BE: The life and times of the Enterococcus. Clin Microbiol Rev. 1990, 3: 45-65.

188.

Garbino J, Villiger P, Caviezel A, Matulionyte R, Uckay I, Morel P, Lew D: A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections. Infection. 2007, 35 (3): 161-166. 10.1007/s15010-007-6237-2.PubMed

189.

Ho J, Tambyah PA, Paterson DL: Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis. 2010, 23 (6): 546-53. 10.1097/QCO.0b013e32833f0d3e.PubMed

190.

Hammond ML: Ertapenem: A Group 1 carbapenem with distinct antibacterial and pharmacological properties. J Antimicrob Chemother. 2004, 53 (Suppl 2): ii7-9. 10.1093/jac/dkh203.PubMed

191.

Falagas ME, Peppas G, Makris GC, Karageorgopoulos DE, Matthaiou DK: Meta-analysis: Ertapenem for complicated intra-abdominal infections. Aliment Pharmacol Ther. 2008, 27 (10): 919-931. 10.1111/j.1365-2036.2008.03642.x.PubMed

192.

Chahine EB, Ferrill MJ, Poulakos MN: Doripenem: A new carbapenem antibiotic. Am J Health Syst Pharm. 2010, 67 (23): 2015-24. 10.2146/ajhp090672.PubMed

193.

Borcherding SM, Stevens R, Nicholas RA, Corley CR, Self T: Quinolones: A practical review of clinical uses, dosing considerations, and drug interactions. J Fam Pract. 1996, 42: 69-78.PubMed

194.

Falagas ME, Matthaiou DK, Bliziotis IA: Systematic review: Fluoroquinolones for the treatment of intra-abdominal surgical infections. Aliment Pharmacol Ther. 2007, 25 (2): 123-131. 10.1111/j.1365-2036.2006.03154.x.PubMed

195.

Weiss G, Reimnitz P, Hampel B, Muehlhofer E, Lippert H, AIDA Study Group: Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study). J Chemother. 2009, 21 (2): 170-180.PubMed

196.

Stein GE: Pharmacokinetics and pharmacodynamics of newer fluoroquinolones. Clin Infect Dis. 1996, 23 (suppl 1): S19-24.PubMed

197.

Edmiston CE, Krepel CJ, Seabrook GR, Somberg LR, Nakeeb A, Cambria RA, Towne JB: In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections. Antimicrob Agents Chemother. 2004, 48 (3): 1012-1016. 10.1128/AAC.48.3.1012-1016.2004.PubMedCentralPubMed

198.

Goldstein EJ, Citron DM, Warren YA, Tyrrell KL, Merriam CV, Fernandez H: In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections. Antimicrob Agents Chemother. 2006, 50 (1): 148-155. 10.1128/AAC.50.1.148-155.2006.PubMedCentralPubMed

199.

Solomkin J, Zhao YP, Ma EL, Chen MJ, Hampel B: DRAGON Study Team. Int J Antimicrob Agents. 2009, 34 (5): 439-445. 10.1016/j.ijantimicag.2009.06.022.PubMed

200.

Wagner C, Sauermann R, Joukhadar C: Principles of antibiotic penetration into abscess fluid. Pharmacology. 2006, 78 (1): 1-10. 10.1159/000094668.PubMed

201.

Bradford PA: Tigecycline: A first in class glycylcycline. Clin Microbiol Newsl. 2004, 26: 163-168. 10.1016/j.clinmicnews.2004.10.001.

202.

Townsend ML, Pound MW, Drew RH: Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections. Ther Clin Risk Manag. 2007, 3 (6): 1059-1070.PubMedCentralPubMed

203.

Boucher HW, Wennersten CB, Eliopoulos GM: In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria. Antimicrob Agents Chemother. 2000, 44: 2225-2229. 10.1128/AAC.44.8.2225-2229.2000.PubMedCentralPubMed

204.

Papaparaskevas J, Tzouvelekis LS, Tsakris A, Pittaras TE, Legakis NJ, Hellenic Tigecycline Study Group: In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints. Diagn Microbiol Infect Dis. 2010, 66 (2): 187-194. 10.1016/j.diagmicrobio.2009.09.012.PubMed

205.

Giamarellou H, Poulakou G: Multidrug-resistant Gram-negative infections: What are the treatment options?. Drugs. 2009, 69 (14): 1879-1901. 10.2165/11315690-000000000-00000.PubMed

206.

Hirsch EB, Tam VH: Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother. 2010, 65 (6): 1119-25. 10.1093/jac/dkq108.PubMed

207.

Hoffmann M, DeMaio W, Jordan RA, Talaat R, Harper D, Speth J, Scatina J: Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects. Drug Metab Dispos. 2007, 35 (9): 1543-53. 10.1124/dmd.107.015735.PubMed

208.

Rodvold KA, Gotfried MH, Cwik M, Korth-Bradley JM, Dukart G, Ellis-Grosse EJ: Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose. J Antimicrob Chemother. 2006, 58 (6): 1221-9. 10.1093/jac/dkl403.PubMed

209.

Eagye KJ, Kuti JL, Dowzicky M, Nicolau DP: Empiric therapy for secondary peritonitis: a pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation. Clin Ther. 2007, 29 (5): 889-99. 10.1016/j.clinthera.2007.05.018.PubMed

210.

Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E, Tigecycline 301 Study Group: The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis. 2005, 41 (Suppl 5): S354-67. 10.1086/431676.PubMed

211.

Towfigh S, Pasternak J, Poirier A, Leister H, Babinchak T: A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections. Clin Microbiol Infect. 2010, 16 (8): 1274-81. 10.1111/j.1469-0691.2010.03122.x.PubMed

212.

Yoshida M, Takada T, Kawarada Y: Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007, 14: 83-90. 10.1007/s00534-006-1160-y.PubMedCentralPubMed

213.

Takada T, Kawarada Y, Nimura Y: Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Surg. 2007, 14: 1-10. 10.1007/s00534-006-1150-0.PubMedCentralPubMed

214.

Mayumi T, Takada T, Kawarada Y: Results of the Tokyo Consensus Meeting Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007, 14: 114-21. 10.1007/s00534-006-1163-8.PubMedCentralPubMed

215.

Kiviluoto T, Sirén J, Luukkonen P, Kivilaakso E: Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis. Lancet. 1998, 351 (9099): 321-5. 10.1016/S0140-6736(97)08447-X.PubMed

216.

Johansson M, Thune A, Nelvin L, Stiernstam M, Westman B, Lundell L: Randomized clinical trial of open versus laparoscopic cholecystectomy in the treatment of acute cholecystitis. Br J Surg. 2005, 92 (1): 44-9. 10.1002/bjs.4836.PubMed

217.

Kum CK, Goh PMY, Isaac JR, Tekant Y, Ngoi SS: Laparoscopic cholecystectomy for acute cholecystitis. Br J Surg. 1994, 81: 1651-1654. 10.1002/bjs.1800811130.PubMed

218.

Chau CH, Tang CN, Siu WT, Ha JP, Li MK: Laparoscopic cholecystectomy versus open cholecystectomy in elderly patients with acute cholecystitis: retrospective study. Hong Kong Med. 2002, J8: 394-399.

219.

Pessaux P, Regenet N, Tuech JJ, Rouge C, Bergamaschi R, Arnaud JP: Laparoscopic versus open cholecystectomy: a prospective comparative study in the elderly with acute cholecystitis. Surg Laparosc Endosc Percutan Tech. 2001, 11: 252-255. 10.1097/00129689-200108000-00005.PubMed

220.

Lujan JA, Parrilla P, Robles R, Marin P, Torralba JA, Garcia-Ayllon J: Laparoscopic chole cystectomy vs open cholecystectomy in the treatment of acute cholecystitis: a prospective study. Arch Surg. 1998, 133: 173-175. 10.1001/archsurg.133.2.173.PubMed

221.

Gurusamy K, Samraj K, Gluud C, Wilson E, Davidson BR: Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg. 2010, 97 (2): 141-50. 10.1002/bjs.6870.PubMed

222.

Siddiqui T, MacDonald A, Chong PS, Jenkins JT: Early versus delayed laparoscopic cholecystectomy for acute cholecystitis: a meta-analysis of randomized clinical trials. Am J Surg. 2008, 195 (1): 40-7. 10.1016/j.amjsurg.2007.03.004.PubMed

223.

Lau H, Lo CY, Patil NG, Yuen WK: Early versus delayed-interval laparoscopic cholecystectomy for acute cholecystitis: a meta-analysis. Surg Endosc. 2006, 20 (1): 82-7. 10.1007/s00464-005-0100-2.PubMed

224.

Papi C, Catarci M, D'Ambrosio L, Gili L, Koch M, Grassi GB, Capurso L: Timing of cholecystectomy for acute calculous cholecystitis: a meta-analysis. Am J Gastroenterol. 2004, 99 (1): 147-55. 10.1046/j.1572-0241.2003.04002.x.PubMed

225.

Hadad SM, Vaidya JS, Baker L, Koh HC, Heron TP, Hussain K, Thompson AM: Delay from symptom onset increases the conversion rate in laparoscopic cholecystectomy for acute cholecystitis. World J Surg. 2007, 31 (6): 1298-01. 10.1007/s00268-007-9050-2. discussion 1302-3.PubMed

226.

Winbladh A, Gullstrand P, Svanvik J, Sandström P: Systematic review of cholecystostomy as a treatment option in acute cholecystitis. HPB (Oxford). 2009, 11 (3): 183-93.

227.

Menakuru SR, Kaman L, Behera A, Singh R, Katariya RN: Current management of gall bladder perforations. ANZ J Surg. 2004, 74: 843-846. 10.1111/j.1445-1433.2004.03186.x.PubMed

228.

Roslyn JJ, Thompson JE, Darvin H, DenBesten L: Risk factors for gallbladder perforation. Am J Gastroenterol. 1987, 82: 636-640.PubMed

229.

Ong CL, Wong TH, Rauff A: Acute gall bladder perforation-a dilemma in early diagnosis. Gut. 1991, 32: 956-958. 10.1136/gut.32.8.956.PubMedCentralPubMed

230.

Stefanidis D, Sirinek KR, Bingener J: Gallbladder perforation: risk factors and outcome. J Surg Res. 2006, 131 (2): 204-8. 10.1016/j.jss.2005.11.580. Epub 2006 Jan 18PubMed

231.

O'Connor MJ, Schwartz ML, McQuarrie DG, Sumer HW: Acute bacterial cholangitis: an analysis of clinical manifestation. Arch Surg. 1982, 117: 437-41. 2PubMed

232.

Welch JP, Donaldson GA: The urgency of diagnosis and surgical treatment of acute suppurative cholangitis. Am J Surg. 1976, 131: 527-32. 10.1016/0002-9610(76)90003-9.PubMed

233.

Lai EC, Mok FP, Tan ES, Lo CM, Fan ST, You KT, Wong J: Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med. 1992, 24: 1582-6. 10.1056/NEJM199206113262401.

234.

Lee DWH, Chung SCS: Biliary infection. Baillieres Clin Gastroenterol. 1997, 11: 707-24. 10.1016/S0950-3528(97)90017-8.PubMed

235.

Lipsett PA, Pitt HA: Acute cholangitis. Surg Clin North Am. 1990, 70: 1297-312.PubMed

236.

Hanau LH, Steigbigel NH: Acute cholangitis. Infect Dis Clin North Am. 2000, 14: 521-46. 10.1016/S0891-5520(05)70119-7.PubMed

237.

Lee JG: Diagnosis and management of acute cholangitis. Nat Rev Gastroenterol Hepatol. 2009, 6 (9): 533-41. 10.1038/nrgastro.2009.126.PubMed

238.

Saltzstein EC, Peacock JB, Mercer LC: Early operation for acute biliary tract stone disease. Surgery. 1983, 94: 704-8.PubMed

239.

Westphal JF, Brogard JM: Biliary tract infections: a guide to drug treatment. Drugs. 1999, 57 (1): 81-91. 10.2165/00003495-199957010-00007.PubMed

240.

Jarvinen H: Biliary bacteremia at various stages of acute cholecystitis. Acta Chir Scand. 1980, 146: 427-30.PubMed

241.

Westphal J, Brogard J: Biliary tract infections: a guide to drug treatment. Drugs. 1999, 57: 81-91. 10.2165/00003495-199957010-00007.PubMed

242.

Sinanan M: Acute cholangitis. Infect Dis Clin North Am. 1992, 6: 571-99.PubMed

243.

Blenkharn J, Habib N, Mok D, John L, McPherson G, Gibson R: Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundice. Antimicrob Agents Chemother. 1985, 28: 778-80.PubMedCentralPubMed

244.

van den Hazel S, De Vries X, Speelman P, Dankert J, Tytgat G, Huibregtse K: Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract. Antimicrob Agents Chemother. 1996, 40: 2658-60.PubMedCentralPubMed

245.

Levi J, Martinez O, Malinin T, Zeppa R, Livingstone A, Hutson D: Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstruction. Antimicrob Agents Chemother. 1984, 26: 944-6.PubMedCentralPubMed

246.

Tanaka A, Takada T, Kawarada Y, Nimura Y, Yoshida M, Miura F, Hirota M, Wada K, Mayumi T, Gomi H, Solomkin JS, Strasberg SM, Pitt HA, Belghiti J, de Santibanes E, Padbury R, Chen MF, Belli G, Ker CG, Hilvano SC, Fan ST, Liau KH: Antimicrobial therapy for acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007, 14 (1): 59-67. 10.1007/s00534-006-1157-6. Epub 2007 Jan 30PubMedCentralPubMed

247.

Pacelli F, Doglietto GB, Alfieri S: Prognosis in intraabdominal infection. Multivariate analysis in 604 patients. Arch Surg. 1996, 131: 641-645.PubMed

248.

Roehrborn A, Thomas L, Potreck O, Ebener C, Ohmann C, Goretzki P, Röher H: The microbiology of postoperative peritonitis. Clin Infect Dis. 2001, 33: 1513-1519. 10.1086/323333.PubMed

249.

Torer N, Yorganci K, Elker D, Sayek I: Prognostic factors of the mortality of postoperative intraabdominal infections. Infection. 2010

250.

Mulier S, Penninckx F, Verwaest C, Filez L, Aerts R, Fieuws S, Lauwers P: Factors affecting ortality in generalized postoperative peritonitis: multivariate analysis in 96 patients. World J Surg. 2003, 27 (4): 379-84. 10.1007/s00268-002-6705-x.PubMed

251.

Khamphommala L, Parc Y, Bennis M, Ollivier JM, Dehni N, Tiret E, Parc R: Results of an aggressive surgical approach in the management of postoperative peritonitis. ANZ J Surg. 2008, 78 (10): 881-8. 10.1111/j.1445-2197.2008.04685.x.PubMed

252.

Parc Y, Frileux P, Schmitt G, Dehni N, Ollivier JM, Parc R: Management of postoperative peritonitis after anterior resection: experience from a referral intensive care unit. Dis Colon Rectum. 2000, 43 (5): 579-587. 10.1007/BF02235565.PubMed

253.

Bohnen J, Boulanger M, Meakins JL, McLean AP: Prognosis in generalized peritonitis. Relation to cause and risk factors. Arch Surg. 1983, 118 (3): 285-90.PubMed

254.

Montravers P, Chalfine A, Gauzit R, Lepape A, Pierre Marmuse J, Vouillot C, Martin C: Clinical and therapeutic features of nonpostoperative nosocomial intra-abdominal infections. Ann Surg. 2004, 239 (3): 409-16. 10.1097/01.sla.0000114214.68169.e9.PubMedCentralPubMed

255.

Ordoñez CA, Puyana JC: Management of peritonitis in the critically ill patient. Surg Clin North Am. 2006, 86 (6): 1323-49.PubMedCentralPubMed

256.

Inui T, Haridas M, Claridge JA, Malangoni MA: Mortality for intra-abdominal infection is associated with intrinsic risk factors rather than the source of infection. Surgery. 2009, 146 (4): 654-61. 10.1016/j.surg.2009.06.051. discussion 661-2.ct;146(4):654-61; discussion 661-2.PubMed

257.

Theisen J, Bartels H, Weiss W, Berger H, Stein HJ, Siewert JR: Current concepts of percutaneous abscess drainage in postoperative retention. J Gastrointest Surg. 2005, 9 (2): 280-3. 10.1016/j.gassur.2004.04.008.PubMed

258.

Khurrum Baig M, Hua Zhao R, Batista O, Uriburu JP, Singh JJ, Weiss EG, Nogueras JJ, Wexner SD: Percutaneous postoperative intra-abdominal abscess drainage after elective colorectal surgery. Tech Coloproctol. 2002, 6 (3): 159-64. 10.1007/s101510200036.PubMed

259.

Benoist S, Panis Y, Pannegeon V, Soyer P, Watrin T, Boudiaf M, Valleur P: Can failure of percutaneous drainage of postoperative abdominal abscesses be predicted?. Am J Surg. 2002, 184 (2): 148-53. 10.1016/S0002-9610(02)00912-1.PubMed

260.

Koperna T, Schulz F: Prognosis and treatment of peritonitis. Do we need new scoring systems?. Arch Surg. 1996, 131 (2): 180-6.PubMed

261.

Koperna T, Schulz F: Relaparotomy in peritonitis: prognosis and treatment of patients with persisting intraabdominal infection. World J Surg. 2000, 24 (1): 32-7. 10.1007/s002689910007.PubMed

262.

Farthmann EH, Schoffel U: Principles and limitations of operative management of intraabdominal infections. World J Surg. 1990, 14 (2): 210-217. 10.1007/BF01664875.PubMed

263.

Hutchins RR, Gunning MP, Lucas DN, Allen-Mersh TG, Soni NC: Relaparotomy for suspected intraperitoneal sepsis after abdominal surgery. World J Surg. 2004, 28 (2): 137-41. 10.1007/s00268-003-7067-8.PubMed

264.

van Ruler O, Lamme B, Gouma DJ, Reitsma JB, Boermeester MA: Variables associated with positive findings at relaparotomy in patients with secondary peritonitis. Crit Care Med. 2007, 35 (2): 468-76. 10.1097/01.CCM.0000253399.03545.2D.PubMed

265.

Hutchins RR, Gunning MP, Lucas DN, Allen-Mersh TG, Soni NC: Relaparotomy for suspected intraperitoneal sepsis after abdominal surgery. World J Surg. 2004, 28 (2): 137-41. 10.1007/s00268-003-7067-8.PubMed

266.

Lamme B, Mahler CW, van Ruler O, Gouma DJ, Reitsma JB, Boermeester MA: Clinical predictors of ongoing infection in secondary peritonitis: systematic review. World J Surg. 2006, 30 (12): 2170-81. 10.1007/s00268-005-0333-1.PubMed

267.

van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, de Graaf PW, Lamme B, Gerhards MF, Steller EP, van Till JW, de Borgie CJ, Gouma DJ, Reitsma JB, Boermeester MA, Dutch Peritonitis Study Group: Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA. 2007, 298 (8): 865-72. 10.1001/jama.298.8.865.PubMed

268.

Amin AI, Shaikh IA: Topical negative pressure in managing severe peritonitis: a positive contribution?. World J Gastroenterol. 2009, 15 (27): 3394-7. 10.3748/wjg.15.3394.PubMedCentralPubMed

269.

Adkins AL, Robbins J, Villalba M, Bendick P, Shanley CJ: Open abdomen management of intra-abdominal sepsis. Am Surg. 2004, 70: 137-140.PubMed

270.

Schein M: Planned reoperations and open management in critical intra-abdominal infections: prospective experience in 52 cases. World J Surg. 1991, 15: 537-545. 10.1007/BF01675658.PubMed

271.

Robledo FA, Luque-de-León E, Suárez R, Sánchez P, de-la-Fuente M, Vargas A, Mier J: Open versus closed management of the abdomen in the surgical treatment of severe secondary peritonitis: a randomized clinical trial. Surg Infect Larchmt. 2007, 8 (1): 63-72. 10.1089/sur.2006.8.016.PubMed

272.

Linden PK: Optimizing therapy for vancomycin-resistant Enterococci (VRE). Semin Respir Crit Care Med. 2007, 28: 632-645. 10.1055/s-2007-996410.PubMed

273.

Chou YY, Lin TY, Lin JC, Wang NC, Peng MY, Chang FY: Vancomycin-resistant enterococcal bacteremia: Comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis. J Microbiol Immunol Infect. 2008, 41 (2): 124-129.PubMed

274.

Jean SS, Fang CT, Wang HK, Hsueh PR, Chang SC, Luh KT: Invasive infections due to vancomycin-resistant Enterococci in adult patients. J Microbiol Immunol Infect. 2001, 34: 281-286.PubMed

275.

Noskin GA: Vancomycin-resistant Enterococci: Clinical, microbiologic, and epidemiologic features. J Lab Clin Med. 1997, 130: 14-20. 10.1016/S0022-2143(97)90054-8.PubMed

276.

Blot SI, Vandewoude KH, De Waele JJ: Candida peritonitis. Curr Opin Crit Care. 2007, 13 (2): 195-199. 10.1097/MCC.0b013e328028fd92.PubMed

277.

Senn L, Eggimann P, Ksontini R, Pascual A, Demartines N, Bille J, Calandra T, Marchetti O: Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients. Intensive Care Med. 2009, 35 (5): 903-908. 10.1007/s00134-009-1405-8.PubMed

278.

Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD, Infectious Diseases Society of America: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009, 1;48 (5): 503-35. 10.1086/596757.

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

WSES consensus conference: Guidelines for first-line management of intra-abdominal infections

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

Bush animal attacks: management of complex injuries in a resource-limited setting

Surgeon-performed sonographic findings in a traumatic trans-anal rectal perforation

Two weeks delayed bleeding in blunt liver injury: case report and review of the literature

Reexpansion pulmonary edema following a posttraumatic pneumothorax: a case report and review of the literature

A technical modification for percutaneous tracheostomy: prospective case series study on one hundred patients

Role of clinical judgment and tissue harmonic imaging ultrasonography in diagnosis of paediatric acute appendicitis